Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMT and High Dose PT/Cy for Renal Allograft Tolerance
NCT02029638Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2014
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in kidney transplantation, sponsored by National Institute of Allergy and Infectious Diseases. Started Jan 2014; status: terminated.
02
Drugs
cyclophosphamide
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT02029638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02029638.